Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Thymol is a monoterpene phenol derived from thyme oil that exhibits antimicrobial activity by disrupting bacterial cell membranes. This phenolic compound provides antioxidant protection through its hydroxyl group that neutralizes hydroxyl free radicals.
Origin & History
Thymol (2-isopropyl-5-methylphenol) is a colorless crystalline monoterpene phenol naturally occurring in essential oils of plants in the Lamiaceae family, particularly Thymus vulgaris (common thyme), yielding 20-30% thymol by weight. It is extracted through fractional distillation followed by extraction and recrystallization, or produced synthetically via alkylation of m-cresol with propene.
Research Narrative (Provisional)
The research dossier explicitly notes the absence of human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs documenting clinical efficacy in human populations. All available evidence is limited to preclinical pharmacological properties and traditional use documentation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Thymol (2-isopropyl-5-methylphenol) is a pure monoterpene phenol compound (molecular weight 150.22 g/mol), not a food ingredient with conventional macronutrient or micronutrient composition. As an isolated bioactive compound, its profile is characterized entirely by its single active constituent. Macronutrients: negligible caloric contribution at typical usage concentrations (0.1–1% in formulations; ~1–50 mg/kg in thyme-derived food applications). Micronutrients: none inherent to the isolated compound. Bioactive compound concentration: when derived from thyme essential oil, thymol constitutes approximately 20–55% of the oil by mass; in pure form it is 100% thymol (CAS 89-83-8). Phenolic hydroxyl group content: one per molecule, conferring hydrogen-donating antioxidant capacity measured at approximately 1.0–1.5 Trolox equivalents per mmol in DPPH assay models (preclinical in vitro data). Bioavailability: lipophilic compound (log P ≈ 3.3), moderately absorbed via oral and dermal routes; rapidly metabolized in mammals via glucuronide and sulfate conjugation in the liver; estimated oral bioavailability in animal models at 20–40% with peak plasma concentrations reached within 1–2 hours at pharmacological doses. No dietary fiber, protein, vitamins, or mineral content applicable to this isolated compound.
Reported Mechanism (Provisional)
Thymol disrupts bacterial cytoplasmic membranes by integrating into lipid bilayers and altering membrane permeability, leading to cell death. The phenolic hydroxyl group acts as an electron donor to neutralize hydroxyl free radicals and other reactive oxygen species. These dual mechanisms contribute to thymol's antimicrobial and antioxidant properties at the cellular level.
Clinical Narrative (Provisional)
Current evidence for thymol is limited to preclinical studies and traditional use applications. Laboratory studies have demonstrated antimicrobial activity against various bacterial strains through membrane disruption mechanisms. Antioxidant activity has been confirmed in vitro through free radical scavenging assays. No randomized controlled trials have been published evaluating thymol supplementation in humans, though topical thymol preparations have traditional use for fungal infections like tinea.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.